Less-than-stellar phase 3 results with Novo Nordisk's highly anticipated obesity therapy CagriSema have caused its shares to ...

While Neuralink has been grabbing headlines due to its association with controversial billionaire Musk, other companies - ...

Vertex Pharma's non-opioid painkiller suzetrigine was unable to perform better than placebo in a phase 2 trial in lumbar ...

Dermatology specialist Galderma has claimed a second FDA approval for IL-31 inhibitor Nemluvio, adding atopic dermatitis to ...

First-degree murder charges are applied when there is suspicion of premeditated, intentional killing, while second-degree ...

Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been ...

Novartis has said it will shut down two MorphoSys sites in Germany and the US, with the loss of around 330 jobs, after ...

China is the fourth major market where Kisunla has been approved after the US, Japan, and GB. It gets the green light there ...

Anglo-US biotech Ottimo Pharma has completed a big early-stage biotech financing, raising $140 million for its PD-1 and VEGF ...

The 2022 Inflation Reduction Act (IRA) has introduced significant challenges for the pharmaceutical industry, altering the ...

Recruiting for clinical trials is hard… and expensive. And a large component of that time involves people sifting through ...

Specifically, that could include a ban on spread pricing – when a PBM reimburses pharmacies one price for a medicine, but ...